Larry L Wood Edwards Lifesciences Corp (EW) insider trading activity

Larry L Wood is Global President TAVR & Surg of Edwards Lifesciences Corp. Currently has a direct ownership of 206,900 shares of EW, which is worth approximately $16.2 Million. The most recent transaction as insider was on Aug 10, 2021, when has been sold 7,830 shares (Common Stock) at a price of $114.14 per share, resulting in proceeds of $893,716. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 207K

4.39% 3M change

7.44% 12M change

Total Value Held $16.2 Million

Larry L Wood Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 10 2021	SELL Open market or private sale	$893,716 $114.14 p/Share	7,830 Reduced 2.06%	372,133 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.02%	379,963 Common Stock
Jul 12 2021	SELL Open market or private sale	$841,568 $107.48 p/Share	7,830 Reduced 2.06%	372,133 Common Stock
Jul 12 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.02%	379,963 Common Stock
Jun 14 2021	SELL Open market or private sale	$782,295 $99.91 p/Share	7,830 Reduced 2.06%	372,071 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.02%	379,901 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$886,577 $89.49 p/Share	9,907 Reduced 2.59%	372,071 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	-	16,406 Added 4.12%	381,978 Common Stock
May 11 2021	SELL Payment of exercise price or tax liability	$190,382 $90.4 p/Share	2,106 Reduced 0.57%	365,572 Common Stock
May 10 2021	SELL Open market or private sale	$722,083 $92.22 p/Share	7,830 Reduced 2.09%	367,678 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.04%	375,508 Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$62,298 $91.75 p/Share	679 Reduced 0.18%	367,678 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	4,575 Added 1.23%	368,357 Common Stock
Apr 12 2021	SELL Open market or private sale	$672,127 $85.84 p/Share	7,830 Reduced 2.11%	363,782 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.06%	371,612 Common Stock
Mar 01 2021	SELL Open market or private sale	$657,642 $83.99 p/Share	7,830 Reduced 2.11%	363,482 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$275,616 $35.2 p/Share	7,830 Added 2.07%	371,312 Common Stock
Dec 15 2020	SELL Open market or private sale	$906,009 $84.5 p/Share	10,722 Reduced 2.87%	363,482 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$233,311 $21.76 p/Share	10,722 Added 2.79%	374,204 Common Stock
Nov 02 2020	SELL Open market or private sale	$783,842 $73.27 p/Share	10,698 Reduced 2.86%	363,482 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$232,788 $21.76 p/Share	10,698 Added 2.78%	374,180 Common Stock
Oct 01 2020	SELL Open market or private sale	$859,905 $80.38 p/Share	10,698 Reduced 2.86%	363,482 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$232,788 $21.76 p/Share	10,698 Added 2.78%	374,180 Common Stock

Also insider at

PRCT

PROCEPT BioRobotics Corp Healthcare

Director

LLW

Larry L Wood

Global President TAVR & Surg

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account